Mechanical stress up-regulates RANKL expression via the VEGF autocrine pathway in osteoblastic MC3T3-E1 cells

Molecular Medicine Reports

Volumn 2, Issue 2, 2009, Pages 229-234

  Nakai, Takeshi ^a   Yoshimura, Yoshitaka ^a   Deyama, Yoshiaki ^a   Suzuki, Kuniaki ^a   Iida, Junichiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Flexercell tension system; Mechanical stress; Osteoblast; Vascular endothelial growth factor

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BONE REMODELING; CELL STRESS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE EXPRESSION REGULATION; MECHANICAL STRESS; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; RECEPTOR UPREGULATION; UPREGULATION;

MURINAE;

EID: 69249096181     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000088     Document Type: Article

References (42)

1. Yoshida H, Hayashi S, Kunisada T, et al: The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345: 442-444, 1990. (Pubitemid 120014957)
2. Lacey DL, Timms E, Tan HL, Kelley MJ, et al: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93: 165-176, 1998. (Pubitemid 28180851)
3. Udagawa N, Takahashi N, Jimi E, et al: Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor: receptor activator of NF-kappa B ligand. Bone 25: 517-523, 1999.
4. Nakagawa N, Kinosaki M, Yamaguchi K, et al: RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun 253: 395-400, 1998. (Pubitemid 29026714)
5. Udagawa N, Takahashi N, Yasuda H, et al: Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141: 3478-3484, 2000. (Pubitemid 32269038)
6. Boyle WJ, Simonet WS and Lacey DL: Osteoclast differentiation and activation. Nature 423: 337-342, 2003.
7. Mochizuki A, Takami M, Kawawa T, et al: Identification and characterization of the precursors committed to osteoclasts induced by TNF-related activation-induced cytokine/receptor activator of NF-κB ligand. J Immunol 177: 4360-4368, 2006. (Pubitemid 44469764)
8. Leung DW, Cachianes G, Kuang WJ, Goeddel DV and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989. (Pubitemid 20066716)
9. Niida S, Kaku M, Amano H, et al: Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med 190: 293-298, 1999. (Pubitemid 29354921)
10. Nakagawa M, Kaneda T, Arakawa T, et al: Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett 473: 161-164, 2000. (Pubitemid 30254282)
11. Carmeliet P, Ferreira V, Breier G, et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435-439, 1996. (Pubitemid 26102719)
12. Ferrara N, Carver-Moore K, Chen H, et al: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380: 439-442, 1996. (Pubitemid 26102720)
13. Ogawa S, Oku A, Sawano A, Yamaguchi S, Yazaki Y and Shibuya M: A novel type of vascular endothelial growth factor, VEGF-E(NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J Biol Chem 273: 31273-31282, 1998. (Pubitemid 28533143)
14. Shibuya M: Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 33: 409-420, 2001. (Pubitemid 32328114)
15. Tombran-Tink J and Barnstable CJ: Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. Biochem Biophys Res Commun 316: 573-579, 2004.
16. Baron RE: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd edition. Favus MJ (ed). Lippincott-Raven, New York, pp3-10, 1996.
17. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE and Lowik CW: Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141: 1667-1674, 2000. (Pubitemid 32274395)
18. Mayr-Wohlfart U, Waletenberger J, Hausser H, et al: Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472-477, 2002. (Pubitemid 34204121)
19. Uchida S, Sakai A, Kudo H, et al: Vascular endothelial growth factor is expressed along with its receptors during the healing process of bone and bone marrow after drill-hole injury in rats. Bone 32: 491-501, 2003. (Pubitemid 39665708)
20. Sato K, Adachi T, Ueda D, Hojo M and Tomita Y: Measurement of local strain on cell membrane at initiation point of calcium signaling response to applied mechanical stimulus in osteoblastic cells. J Biomech 40: 1246-1255, 2007. (Pubitemid 46483459)
21. Jansen JH, Weyts FA, Westbroek I, et al: Stretch-induced phosphorylation of ERK1/2 depends on differentiation stage of osteoblasts. J Cell Biochem 93: 542-551, 2004. (Pubitemid 44264189)
22. Kim DW, Lee HJ, Karmin JA, et al: Mechanical loading differentially regulates membrane-bound and soluble RANKL availability in MC3T3-E1 cells. Ann NY Acad Sci 1068: 568-572, 2006.
23. Motokawa M, Kaku M, Tohma Y, et al: Effects of cyclic tensile forces on the expression of vascular endothelial growth factor (VEGF) and macrophage-colony stimulating factor (M-CSF) in murine osteoblastic MC3T3-E1 cells. J Dent Res 84: 422-427, 2005. (Pubitemid 43827873)
24. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ and Gluck SL: Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272: 22053-22058, 1997. (Pubitemid 27382830)
25. Yang CM, Chien CS, Yao CC, Hsiao LD, Huang YC and Wu CB: Mechanical strain induces collagenase-3 (MMP-13) expression in MC3T3-E1 osteoblastic cells. J Biol Chem 279: 22158-22165, 2004.
26. Yoshimura Y, Kikuiri T, Deyama Y, Hasegawa T, Hatta M and Suzuki K: Hydrostatic pressure stimulates the fusion process in osteoclasts. Dent Jpn 40: 35-37, 2004.
27. Vande Geest JP, Di Mrtino ES and Vorp DA: An analysis of the complete strain field within Flexercell™ membranes. J Biomech 37: 1923-1928, 2004.
28. Suzuki N, Yoshimura Y, Deyama Y, Suzuki K and Kitagawa Y: Mechanical stress directly suppresses osteoclast differentiation in RAW264.7 cells. Int J Mol Med 21: 291-296, 2008. (Pubitemid 351330479)
29. Kaku M, Kohno S, Kawata T, et al: Effects of vascular endothelial growth factor on osteoclast induction during tooth movement in mice. J Dent Res 80: 1880-1883, 2001.
30. Kohno S, Kaku M, Tsutsui K, et al: Expression of vascular endothelial growth factor and the effects on bone remodeling during experimental tooth movement. J Dent Res 82: 177-182, 2003. (Pubitemid 41766039)
31. Kohno S, Kaku M, Kawata T, et al: Neutralizing effects of an anti-vascular endothelial growth factor antibody on tooth movement. Angle Orthod 75: 797-804, 2005. (Pubitemid 41297044)
32. Jimi E, Nakamura I, Amano H, et al: Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology 137: 2187-2190, 1996. (Pubitemid 26133995)
33. Otomo H, Sakai A, Uchida S, et al: Flt-1 tyrosine kinase-deficient homozygous mice result in decreased trabecular bone volume with reduced osteogenic potential. Bone 40: 1494-1501, 2007. (Pubitemid 46756416)
34. Bandow K, Nishikawa Y, Ohnishi T, et al: Low-intensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1beta expression in osteoblasts through the angiotensin II type 1 receptor. J Cell Physiol 211: 392-398, 2007. (Pubitemid 46580093)
35. Weir EC, Horowitz MC, Baron R, Centrella M, Kacinski BM and Insogna KL: Macrophage colony-stimulating factor release and receptor expression in bone cells. J Bone Miner Res 8: 1507-1518, 1993. (Pubitemid 23342689)
36. Ninomiya K, Miyamoto T, Imai J, et al: Osteoclastic activity induces osteomodulin expression in osteoblasts. Biochem Biophys Res Commun 362: 460-466, 2007. (Pubitemid 47332432)
37. Oyajobi BO, Caswell AM and Russell RG: Transforming growth factor beta increases ecto-nucleoside triphosphate pyrophosphatase activity of human bone-derived cells. J Bone Miner Res 9: 99-109, 1994. (Pubitemid 24010845)
38. Murshed M, Harmey D, Millán JL, McKee MD and Karsenty G: Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19: 1093-1104, 2005. (Pubitemid 40632454)
39. Sandberg M, Vuorio T, Hirvonen H, Alitalo K and Vuorio E: Enhanced expression of TGF-beta and c-fos mRNAs in the growth plates of developing human long bones. Development 102: 461-470, 1988. (Pubitemid 18084929)
40. Knauper V, Lopez-Otin C, Smith B, Knight G and Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544-1550, 1996.
41. Fosang AJ, Last K, Knauper V, Murphy G and Neame PJ: Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380: 17-20, 1996. (Pubitemid 26058726)
42. Nakamura H, Sato G, Hirata A and Yamamoto T: Immunolocalization of matrix metalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone 34: 48-56, 2004. (Pubitemid 38142433)